Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
July 12, 2012
Protocol for the clonal analysis of NK cell effector functions by multi-parameter flow cytometry
Kathrin Schönberg, Maryam Hejazi, Markus Uhrberg
Blood
|
March 19, 2011
Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I
Kathrin Schönberg, Johannes C Fischer, Gesine Kögler, et al.
Oncoimmunology
|
April 9, 2016
Get a grip on immune cells by inhibiting JAKs
Kathrin Schönberg, Janna Rudolph, Sowmya Parampalli Yajnanarayana, et al.
Blood
|
October 12, 2010
Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition
Kathrin Schönberg, Martina Sribar, Jürgen Enczmann, et al.
Oncoimmunology
|
March 5, 2016
Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors
Stefanie Andrea Erika Held, Annkristin Heine, Anne Ruth Kesper, et al.
Haematologica
|
February 16, 2015
Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes
Maryam Hejazi, Angela R Manser, Julia Fröbel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 2, 2010
Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation
Silvia Rathmann, Sabine Glatzel, Kathrin Schönberg, et al.
Cancer Immunology, Immunotherapy : CII
|
September 15, 2012
T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16
Lisa M Pörtner, Kathrin Schönberg, Maryam Hejazi, et al.
British Journal of Haematology
|
April 1, 2015
JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms
Sowmya Parampalli Yajnanarayana, Thomas Stübig, Isabelle Cornez, et al.
Cancer Research
|
April 3, 2015
JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms
Kathrin Schönberg, Janna Rudolph, Maria Vonnahme, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Methods in Molecular Biology (Clifton, N.J.)
|
July 12, 2012
Protocol for the clonal analysis of NK cell effector functions by multi-parameter flow cytometry
Kathrin Schönberg, Maryam Hejazi, Markus Uhrberg
Blood
|
March 19, 2011
Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I
Kathrin Schönberg, Johannes C Fischer, Gesine Kögler, et al.
Oncoimmunology
|
April 9, 2016
Get a grip on immune cells by inhibiting JAKs
Kathrin Schönberg, Janna Rudolph, Sowmya Parampalli Yajnanarayana, et al.
Blood
|
October 12, 2010
Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition
Kathrin Schönberg, Martina Sribar, Jürgen Enczmann, et al.
Oncoimmunology
|
March 5, 2016
Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors
Stefanie Andrea Erika Held, Annkristin Heine, Anne Ruth Kesper, et al.
Haematologica
|
February 16, 2015
Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes
Maryam Hejazi, Angela R Manser, Julia Fröbel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 2, 2010
Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation
Silvia Rathmann, Sabine Glatzel, Kathrin Schönberg, et al.
Cancer Immunology, Immunotherapy : CII
|
September 15, 2012
T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16
Lisa M Pörtner, Kathrin Schönberg, Maryam Hejazi, et al.
British Journal of Haematology
|
April 1, 2015
JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms
Sowmya Parampalli Yajnanarayana, Thomas Stübig, Isabelle Cornez, et al.
Cancer Research
|
April 3, 2015
JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms
Kathrin Schönberg, Janna Rudolph, Maria Vonnahme, et al.
Page
of 1